Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 168 articles: HTML format

Single Articles

October 2021
1. DOMNICH A, De Pace V, Pennati BM, Caligiuri P, et al
   Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics.
   Arch Virol. 2021;166:2825-2828.
   PubMed     Abstract available
   
   
   
2. HU J, Stojanovic J, Yasamineh S, Yasamineh P, et al
   The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.
   Arch Virol. 2021;166:2649-2672.
   PubMed     Abstract available
   
   
   September 2021
3. LAVERACK M, Tallmadge RL, Venugopalan R, Cronk B, et al
   Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
   Arch Virol. 2021;166:2551-2561.
   PubMed     Abstract available
   
   
   
4. NAGY A, Basiouni S, Parvin R, Hafez HM, et al
   Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
   Arch Virol. 2021;166:2541-2549.
   PubMed     Abstract available
   
   
   
5. MARCHIO A, Batejat C, Vanhomwegen J, Feher M, et al
   ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.
   Arch Virol. 2021;166:2529-2540.
   PubMed     Abstract available
   
   
   
6. ABDELWAHAB SF, Mohamed MK, Ali WY, Ali AS, et al
   Role of polymeric materials in preventing COVID-19 infection.
   Arch Virol. 2021;166:2487-2493.
   PubMed     Abstract available
   
   
   
7. BOONARKART C, Suptawiwat O, Ruangrung K, Maneechotesuwan K, et al
   Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus.
   Arch Virol. 2021;166:2579-2584.
   PubMed     Abstract available
   
   
   
8. MA Y, Jiang H, Wan Z, Li S, et al
   Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018.
   Arch Virol. 2021;166:2407-2418.
   PubMed     Abstract available
   
   
   August 2021
9. PENG J, Liu ZY, Yu XJ, Chen XY, et al
   Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.
   Arch Virol. 2021;166:2299-2303.
   PubMed     Abstract available
   
   
   
10. SHABBIR S, Raza MH, Arshad M, Khan MJ, et al
    The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Arch Virol. 2021;166:2109-2117.
    PubMed     Abstract available
    
    
    
11. HASHEMI SMA, Thijssen M, Hosseini SY, Tabarraei A, et al
    Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
    Arch Virol. 2021;166:2089-2108.
    PubMed     Abstract available
    
    
    
12. ZHANG L, Hou J, Ma FZ, Li J, et al
    The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis.
    Arch Virol. 2021;166:2071-2087.
    PubMed     Abstract available
    
    
    July 2021
13. ZHOU S, Mao N, Zhang Y, Cui A, et al
    Genetic analysis of human parainfluenza virus type 4 associated with severe acute respiratory infection in children in Luohe City, Henan Province, China, during 2017-2018.
    Arch Virol. 2021 Jul 6. pii: 10.1007/s00705-021-05154.
    PubMed     Abstract available
    
    
    
14. YUAN HW, Wen HL
    Research progress on coronavirus S proteins and their receptors.
    Arch Virol. 2021;166:1811-1817.
    PubMed     Abstract available
    
    
    
15. MIRZAEI R, Attar A, Papizadeh S, Jeda AS, et al
    The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
    Arch Virol. 2021;166:1819-1840.
    PubMed     Abstract available
    
    
    June 2021
16. ZENG MS, Yu WD, Wang HX, Xu PP, et al
    Puerarin reduces impairment of intestinal and adipose immune responses to influenza virus infection in mice.
    Arch Virol. 2021 Jun 10. pii: 10.1007/s00705-021-05112.
    PubMed     Abstract available
    
    
    
17. CHEN K, Kong M, Liu J, Jiao J, et al
    Rapid differential detection of subtype H1 and H3 swine influenza viruses using a TaqMan-MGB-based duplex one-step real-time RT-PCR assay.
    Arch Virol. 2021 Jun 6. pii: 10.1007/s00705-021-05127.
    PubMed     Abstract available
    
    
    
18. ROKIC F, Trgovec-Greif L, Sucic N, Cemeljic N, et al
    Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.
    Arch Virol. 2021;166:1735-1739.
    PubMed     Abstract available
    
    
    
19. PEDREANEZ A, Mosquera-Sulbaran J, Munoz N
    SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis.
    Arch Virol. 2021;166:1565-1574.
    PubMed     Abstract available
    
    
    May 2021
20. TANG Y, Yang G, Li Y, Wang M, et al
    Protective effects of SP600125 on mice infected with H1N1 influenza A virus.
    Arch Virol. 2021 May 20. pii: 10.1007/s00705-021-05103.
    PubMed     Abstract available
    
    
    
21. SOKOLOVA AS, Yarovaya OI, Baranova DV, Galochkina AV, et al
    Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus.
    Arch Virol. 2021 May 13. pii: 10.1007/s00705-021-05102.
    PubMed     Abstract available
    
    
    
22. SYLVERKEN AA, El-Duah P, Owusu M, Schneider J, et al
    Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.
    Arch Virol. 2021;166:1385-1393.
    PubMed     Abstract available
    
    
    April 2021
23. GONZALEZ-GARCIA LD, Martinez-Castillo M, Vargas-Pavia TA, Ulloa-Aguilar JM, et al
    Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism.
    Arch Virol. 2021;166:1177-1182.
    PubMed     Abstract available
    
    
    March 2021
24. ZINYAKOV NG, Sosipatorova VY, Andriyasov AV, Ovchinnikova EV, et al
    Genetic analysis of genotype G57 H9N2 avian influenza virus isolate A/chicken/Tajikistan/2379/2018 recovered in Central Asia.
    Arch Virol. 2021 Mar 19. pii: 10.1007/s00705-021-05011.
    PubMed     Abstract available
    
    
    
25. WOUK J, Rechenchoski DZ, Rodrigues BCD, Ribelato EV, et al
    Viral infections and their relationship to neurological disorders.
    Arch Virol. 2021;166:733-753.
    PubMed     Abstract available
    
    
    
26. DOWLATSHAHI S, Shabani E, Abdekhodaie MJ
    Serological assays and host antibody detection in coronavirus-related disease diagnosis.
    Arch Virol. 2021;166:715-731.
    PubMed     Abstract available
    
    
    
27. DABBOUS HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, et al
    Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.
    Arch Virol. 2021;166:949-954.
    PubMed     Abstract available
    
    
    
28. VERMA J, Subbarao N
    A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
    Arch Virol. 2021;166:697-714.
    PubMed     Abstract available
    
    
    
29. SARKAR R, Mitra S, Chandra P, Saha P, et al
    Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.
    Arch Virol. 2021;166:801-812.
    PubMed     Abstract available
    
    
    
30. HEMMAT N, Asadzadeh Z, Ahangar NK, Alemohammad H, et al
    The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
    Arch Virol. 2021;166:675-696.
    PubMed     Abstract available
    
    
    February 2021
31. YANG F, Xiao Y, Liu F, Yao H, et al
    Isolation and characterization of two novel reassortant H5N6 avian influenza viruses from waterfowl in eastern China.
    Arch Virol. 2021 Feb 17. pii: 10.1007/s00705-021-04995.
    PubMed     Abstract available
    
    
    
32. LI Y, Hu J, Lei J, Fan W, et al
    Development and application of a novel triplex protein microarray method for rapid detection of antibodies against avian influenza virus, Newcastle disease virus, and avian infectious bronchitis virus.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04962.
    PubMed     Abstract available
    
    
    
33. TSUNEKI-TOKUNAGA A, Kanai K, Itagaki A, Tsuchie H, et al
    Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04976.
    PubMed     Abstract available
    
    
    January 2021
34. ALLKOFER A, Garvey M, Ryan E, Lyons R, et al
    Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.
    Arch Virol. 2021 Jan 7. pii: 10.1007/s00705-020-04846.
    PubMed     Abstract available
    
    
    
35. SABBAGHI A, Zargar M, Zolfaghari MR, Motamedi-Sedeh F, et al
    Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Arch Virol. 2021 Jan 6. pii: 10.1007/s00705-020-04900.
    PubMed     Abstract available
    
    
    
36. NG KT, Takebe Y, Kamarulzaman A, Tee KK, et al
    Genome sequencing and phylogenetic reconstruction reveal a potential fourth rhinovirus species and its worldwide distribution.
    Arch Virol. 2021;166:225-229.
    PubMed     Abstract available
    
    
    
37. ARANCIO W
    ceRNA analysis of SARS-CoV-2.
    Arch Virol. 2021;166:271-274.
    PubMed     Abstract available
    
    
    
38. MOSQUERA-SULBARAN JA, Hernandez-Fonseca H
    Tetracycline and viruses: a possible treatment for COVID-19?
    Arch Virol. 2021;166:1-7.
    PubMed     Abstract available
    
    
    December 2020
39. REHMAN S, Mahmood T, Aziz E, Batool R, et al
    Identification of novel mutations in SARS-COV-2 isolates from Turkey.
    Arch Virol. 2020;165:2937-2944.
    PubMed     Abstract available
    
    
    November 2020
40. YANG X, Liang Y, Bamunuarachchi G, Xu Y, et al
    miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.
    Arch Virol. 2020 Nov 18. pii: 10.1007/s00705-020-04877.
    PubMed     Abstract available
    
    
    
41. LIU B, Wang Y, Liu Y, Chen Y, et al
    Molecular evolution and characterization of hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 viruses isolated in Beijing, China, during the 2017-2018 and 2018-2019 influenza seasons.
    Arch Virol. 2020 Nov 3. pii: 10.1007/s00705-020-04869.
    PubMed     Abstract available
    
    
    
42. DADAR M, Fakhri Y, Bjorklund G, Shahali Y, et al
    The association between the incidence of COVID-19 and the distance from the virus epicenter in Iran.
    Arch Virol. 2020;165:2555-2560.
    PubMed     Abstract available
    
    
    
43. SHAMIM S, Khan M, Kharaba ZJ, Ijaz M, et al
    Potential strategies for combating COVID-19.
    Arch Virol. 2020;165:2419-2438.
    PubMed     Abstract available
    
    
    October 2020
44. GROHN S, Heinimaki S, Tamminen K, Blazevic V, et al
    Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform.
    Arch Virol. 2020 Oct 16. pii: 10.1007/s00705-020-04847.
    PubMed     Abstract available
    
    
    
45. CAROSSINO M, Ip HS, Richt JA, Shultz K, et al
    Detection of SARS-CoV-2 by RNAscope((R)) in situ hybridization and immunohistochemistry techniques.
    Arch Virol. 2020;165:2373-2377.
    PubMed     Abstract available
    
    
    
46. GALLAHER WR
    A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
    Arch Virol. 2020;165:2341-2348.
    PubMed     Abstract available
    
    
    
47. JANG Y, Seo SH
    Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
    Arch Virol. 2020;165:2205-2211.
    PubMed     Abstract available
    
    
    September 2020
48. GARCES-AYALA F, Araiza-Rodriguez A, Mendieta-Condado E, Rodriguez-Maldonado AP, et al
    Full genome sequence of the first SARS-CoV-2 detected in Mexico.
    Arch Virol. 2020;165:2095-2098.
    PubMed     Abstract available
    
    
    August 2020
49. KETKLAO S, Boonarkart C, Phakaratsakul S, Auewarakul P, et al
    Responses to the Sb epitope contributed to antigenic drift of the influenza A 2009 H1N1 virus.
    Arch Virol. 2020 Aug 11. pii: 10.1007/s00705-020-04758.
    PubMed     Abstract available
    
    
    
50. LIMA WG, Brito JCM, Overhage J, Nizer WSDC, et al
    The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
    Arch Virol. 2020;165:1729-1737.
    PubMed     Abstract available
    
    
    
51. MCIVER DJ, Silithammavong S, Theppangna W, Gillis A, et al
    Coronavirus surveillance of wildlife in the Lao People's Democratic Republic detects viral RNA in rodents.
    Arch Virol. 2020;165:1869-1875.
    PubMed     Abstract available
    
    
    July 2020
52. DA COSTA VG, Moreli ML, Saivish MV
    The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    Arch Virol. 2020;165:1517-1526.
    PubMed     Abstract available
    
    
    June 2020
53. KOLOSOVA NP, Ilyicheva TN, Danilenko AV, Svyatchenko SV, et al
    Severe cases of seasonal influenza and detection of seasonal A(H1N2) in Russia in 2018-2019.
    Arch Virol. 2020 Jun 10. pii: 10.1007/s00705-020-04699.
    PubMed     Abstract available
    
    
    May 2020
54. YUN KW, Choi EH, Lee HJ
    Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons (1990-2018) and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea.
    Arch Virol. 2020;165:1069-1077.
    PubMed     Abstract available
    
    
    
55. LI H, Cao L, Zhang Y, Ren H, et al
    Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice.
    Arch Virol. 2020;165:1057-1067.
    PubMed     Abstract available
    
    
    April 2020
56. ARBI M, Souiai O, Rego N, Larbi I, et al
    Historical origins and zoonotic potential of avian influenza virus H9N2 in Tunisia revealed by Bayesian analysis and molecular characterization.
    Arch Virol. 2020 Apr 25. pii: 10.1007/s00705-020-04624.
    PubMed     Abstract available
    
    
    
57. YEHIA N, Hassan WMM, Sedeek A, Elhusseiny MH, et al
    Genetic variability of avian influenza virus subtype H5N8 in Egypt in 2017 and 2018.
    Arch Virol. 2020 Apr 13. pii: 10.1007/s00705-020-04621.
    PubMed     Abstract available
    
    
    March 2020
58. LIMSUWAT N, Boonarkart C, Phakaratsakul S, Suptawiwat O, et al
    Influence of cellular lipid content on influenza A virus replication.
    Arch Virol. 2020 Mar 29. pii: 10.1007/s00705-020-04596.
    PubMed     Abstract available
    
    
    
59. JANG Y, Seo T, Seo SH
    Higher virulence of swine H1N2 influenza viruses containing avian-origin HA and 2009 pandemic PA and NP in pigs and mice.
    Arch Virol. 2020 Mar 28. pii: 10.1007/s00705-020-04572.
    PubMed     Abstract available
    
    
    
60. YANG F, Xiao Y, Xu L, Liu F, et al
    Development of an antigen-capture enzyme-linked immunosorbent assay and immunochromatographic strip based on monoclonal antibodies for detection of H6 avian influenza viruses.
    Arch Virol. 2020 Mar 27. pii: 10.1007/s00705-020-04602.
    PubMed     Abstract available
    
    
    
61. SIMMONDS P, Gorbalenya AE, Harvala H, Hovi T, et al
    Recommendations for the nomenclature of enteroviruses and rhinoviruses.
    Arch Virol. 2020;165:793-797.
    PubMed     Abstract available
    
    
    February 2020
62. RAMIREZ-SALINAS GL, Garcia-Machorro J, Rojas-Hernandez S, Campos-Rodriguez R, et al
    Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
    Arch Virol. 2020 Feb 14. pii: 10.1007/s00705-020-04537.
    PubMed     Abstract available
    
    
    January 2020
63. KHALIL AM, Nishi N, Kojima I, Fukunaga W, et al
    Transition in genetic constellations of H3N8 and H4N6 low-pathogenic avian influenza viruses isolated from an overwintering site in Japan throughout different winter seasons.
    Arch Virol. 2020 Jan 10. pii: 10.1007/s00705-019-04519.
    PubMed     Abstract available
    
    
    November 2019
64. EVSEENKO VA, Svyatchenko SV, Kolosova NP, Kovrizhkina VL, et al
    Comparative thermostability analysis of zoonotic and human influenza virus A and B neuraminidase.
    Arch Virol. 2019 Nov 19. pii: 10.1007/s00705-019-04465.
    PubMed     Abstract available
    
    
    
65. TWABELA AT, Okamatsu M, Tshilenge GM, Mpiana S, et al
    Molecular, antigenic, and pathogenic characterization of H5N8 highly pathogenic avian influenza viruses isolated in the Democratic Republic of Congo in 2017.
    Arch Virol. 2019 Nov 9. pii: 10.1007/s00705-019-04456.
    PubMed     Abstract available
    
    
    
66. ZELL R, Groth M, Krumbholz A, Lange J, et al
    Displacement of the Gent/1999 human-like swine H1N2 influenza A virus lineage by novel H1N2 reassortants in Germany.
    Arch Virol. 2019 Nov 6. pii: 10.1007/s00705-019-04457.
    PubMed     Abstract available
    
    
    September 2019
67. SANTIAGO-OLIVARES C, Rivera-Toledo E, Gomez B
    Nitric oxide production is downregulated during respiratory syncytial virus persistence by constitutive expression of arginase 1.
    Arch Virol. 2019;164:2231-2241.
    PubMed     Abstract available
    
    
    August 2019
68. LE TB, Kim HK, Le HY, Jeong MC, et al
    Complete genome sequence of a novel reassortant H3N3 avian influenza virus.
    Arch Virol. 2019 Aug 27. pii: 10.1007/s00705-019-04386.
    PubMed     Abstract available
    
    
    July 2019
69. QI J, Li X, Zhang Y, Shen X, et al
    Development of a duplex reverse transcription recombinase-aided amplification assay for respiratory syncytial virus incorporating an internal control.
    Arch Virol. 2019;164:1843-1850.
    PubMed     Abstract available
    
    
    June 2019
70. NEMOTO M, Yamayoshi S, Bannai H, Tsujimura K, et al
    A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain.
    Arch Virol. 2019 Jun 21. pii: 10.1007/s00705-019-04328.
    PubMed     Abstract available
    
    
    May 2019
71. YU Z, Ren Z, Zhao Y, Cheng K, et al
    PB2 and hemagglutinin mutations confer a virulent phenotype on an H1N2 avian influenza virus in mice.
    Arch Virol. 2019 May 20. pii: 10.1007/s00705-019-04283.
    PubMed     Abstract available
    
    
    
72. ALEXYUK PG, Bogoyavlenskiy AP, Alexyuk MS, Turmagambetova AS, et al
    Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins.
    Arch Virol. 2019 May 11. pii: 10.1007/s00705-019-04273.
    PubMed     Abstract available
    
    
    
73. MATSUMOTO Y, Ohta K, Nishio M
    Importance of tyrosine in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein for polymerase activity.
    Arch Virol. 2019 May 4. pii: 10.1007/s00705-019-04240.
    PubMed     Abstract available
    
    
    
74. DU J, Zhu T, Zhuang L, Zhang PH, et al
    Identification and complete genome characterization of human enterovirus 117 from a child with pneumonia in China.
    Arch Virol. 2019;164:1489-1492.
    PubMed     Abstract available
    
    
    April 2019
75. VANDALEN KK, Nemeth NM, Thomas NO, Barrett NL, et al
    Experimental infections of Norway rats with avian-derived low-pathogenic influenza A viruses.
    Arch Virol. 2019 Apr 11. pii: 10.1007/s00705-019-04225.
    PubMed    
    
    
    March 2019
76. CETINA-MONTEJO L, Ayora-Talavera G, Borges-Argaez R
    Zeylanone epoxide isolated from Diospyros anisandra stem bark inhibits influenza virus in vitro.
    Arch Virol. 2019 Mar 23. pii: 10.1007/s00705-019-04223.
    PubMed     Abstract available
    
    
    
77. LIU J, Zhou L, Lv J, Zou Y, et al
    Two novel reassortant H11N8 avian influenza viruses occur in wild birds found in East Dongting Lake, China.
    Arch Virol. 2019 Mar 8. pii: 10.1007/s00705-019-04168.
    PubMed     Abstract available
    
    
    February 2019
78. ZHANG Z, Liu D, Hu J, Sun W, et al
    Multiplex one-step real-time PCR assay for rapid simultaneous detection of velogenic and mesogenic Newcastle disease virus and H5-subtype avian influenza virus.
    Arch Virol. 2019 Feb 21. pii: 10.1007/s00705-019-04180.
    PubMed     Abstract available
    
    
    
79. NURPEISOVA A, Kassenov M, Rametov N, Tabynov K, et al
    Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine.
    Arch Virol. 2019 Feb 10. pii: 10.1007/s00705-019-04147.
    PubMed     Abstract available
    
    
    
80. ZHU D, Lok C, Chao S, Chen L, et al
    Detection and characterization of type B influenza virus from influenza-like illness cases during the 2017-2018 winter influenza season in Beijing, China.
    Arch Virol. 2019 Feb 7. pii: 10.1007/s00705-019-04160.
    PubMed     Abstract available
    
    
    January 2019
81. HU J, Liang Y, Hu Z, Wang X, et al
    Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Arch Virol. 2019 Jan 22. pii: 10.1007/s00705-018-04142.
    PubMed     Abstract available
    
    
    
82. WEI X, Liu Z, Wang J, Yang R, et al
    The interaction of cellular protein ANP32A with influenza A virus polymerase component PB2 promotes vRNA synthesis.
    Arch Virol. 2019 Jan 21. pii: 10.1007/s00705-018-04139.
    PubMed     Abstract available
    
    
    December 2018
83. TANIKAWA T, Uchida Y, Takemae N, Tsunekuni R, et al
    Pathogenicity of two novel human-origin H7N9 highly pathogenic avian influenza viruses in chickens and ducks.
    Arch Virol. 2018 Dec 11. pii: 10.1007/s00705-018-4102.
    PubMed     Abstract available
    
    
    November 2018
84. ZHANG J, Wu H, Zhang Y, Cao M, et al
    Molecular evolutionary and antigenic characteristics of newly isolated H9N2 avian influenza viruses in Guangdong province, China.
    Arch Virol. 2018 Nov 24. pii: 10.1007/s00705-018-4103.
    PubMed     Abstract available
    
    
    
85. MINE J, Abe H, Parchariyanon S, Boonpornprasert P, et al
    Genetic and antigenic dynamics of influenza A viruses of swine on pig farms in Thailand.
    Arch Virol. 2018 Nov 10. pii: 10.1007/s00705-018-4091.
    PubMed     Abstract available
    
    
    October 2018
86. WU H, Yang F, Liu F, Peng X, et al
    Molecular characterization of H10 subtype avian influenza viruses isolated from poultry in Eastern China.
    Arch Virol. 2018 Oct 9. pii: 10.1007/s00705-018-4019.
    PubMed     Abstract available
    
    
    
87. LEE MS, Jang EY, Cho J, Kim K, et al
    Development and comparison of two H5N8 influenza A vaccine candidate strains.
    Arch Virol. 2018 Oct 5. pii: 10.1007/s00705-018-4062.
    PubMed     Abstract available
    
    
    September 2018
88. INDALAO IL, Sawabuchi T, Takahashi E, Kido H, et al
    Correction to: IL-1b is a key cytokine that induces trypsin upregulation in the influenza virus-cytokine-trypsin cycle.
    Arch Virol. 2018 Sep 28. pii: 10.1007/s00705-018-4043.
    PubMed     Abstract available
    
    
    
89. EVSEENKO VA, Kolosova NP, Gudymo AS, Maltsev SV, et al
    Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract.
    Arch Virol. 2018 Sep 17. pii: 10.1007/s00705-018-4023.
    PubMed     Abstract available
    
    
    
90. LIU J, Xue L, Hu S, Cheng H, et al
    Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Arch Virol. 2018 Sep 5. pii: 10.1007/s00705-018-4016.
    PubMed     Abstract available
    
    
    
91. MADI N, Chehadeh W, Asadzadeh M, Al-Turab M, et al
    Analysis of genetic variability of respiratory syncytial virus groups A and B in Kuwait.
    Arch Virol. 2018;163:2405-2413.
    PubMed     Abstract available
    
    
    August 2018
92. WANITCHANG A, Saenboonrueng J, Srisutthisamphan K, Jongkaewwattana A, et al
    Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus.
    Arch Virol. 2018 Aug 22. pii: 10.1007/s00705-018-4001.
    PubMed     Abstract available
    
    
    
93. DIRSMITH KL, Jeffrey Root J, Bentler KT, Sullivan HJ, et al
    Persistence of maternal antibodies to influenza A virus among captive mallards (Anas platyrhynchos).
    Arch Virol. 2018 Aug 21. pii: 10.1007/s00705-018-3978.
    PubMed     Abstract available
    
    
    July 2018
94. AL KHATIB HA, Al Thani AA, Yassine HM
    Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.
    Arch Virol. 2018 Jul 31. pii: 10.1007/s00705-018-3962.
    PubMed     Abstract available
    
    
    
95. JANG Y, Jin M, Seo SH
    Histamine contributes to severe pneumonia in pigs infected with 2009 pandemic H1N1 influenza virus.
    Arch Virol. 2018 Jul 31. pii: 10.1007/s00705-018-3973.
    PubMed     Abstract available
    
    
    
96. MAEGAWA K, Shibata T, Yamaguchi R, Hiroike K, et al
    Overexpression of a virus-like particle influenza vaccine in Eri silkworm pupae, using Autographa californica nuclear polyhedrosis virus and host-range expansion.
    Arch Virol. 2018 Jul 19. pii: 10.1007/s00705-018-3941.
    PubMed     Abstract available
    
    
    
97. GAO Z, Hu J, Wang X, Yang Q, et al
    The PA-interacting host protein nucleolin acts as an antiviral factor during highly pathogenic H5N1 avian influenza virus infection.
    Arch Virol. 2018 Jul 5. pii: 10.1007/s00705-018-3926.
    PubMed     Abstract available
    
    
    June 2018
98. ROOT JJ, Bosco-Lauth AM, Marlenee NL, Bowen RA, et al
    Cottontail rabbits shed clade 2.3.4.4 H5 highly pathogenic avian influenza A viruses.
    Arch Virol. 2018 Jun 13. pii: 10.1007/s00705-018-3907.
    PubMed     Abstract available
    
    
    
99. ILYICHEVA TN, Durymanov AG, Svyatchenko SV, Marchenko VY, et al
    Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016-2017.
    Arch Virol. 2018 Jun 5. pii: 10.1007/s00705-018-3904.
    PubMed     Abstract available
    
    
    
100. PUTRI K, Wawegama N, Ignjatovic J, Noormohammadi AH, et al
     Characterisation of the antigenic epitopes in the subunit 2 haemagglutinin of avian influenza virus H5N1.
     Arch Virol. 2018 Jun 4. pii: 10.1007/s00705-018-3896.
     PubMed     Abstract available
     
     
     May 2018
101. YANG F, Chen B, Liu F, Peng X, et al
     Development of a TaqMan MGB RT-PCR assay for the detection of type A and subtype H10 avian influenza viruses.
     Arch Virol. 2018 May 23. pii: 10.1007/s00705-018-3889.
     PubMed     Abstract available
     
     
     
102. LEE ACY, To KKW, Zhang AJX, Zhu H, et al
     Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice.
     Arch Virol. 2018 May 7. pii: 10.1007/s00705-018-3852.
     PubMed     Abstract available
     
     
     
103. SULCZEWSKI FB, Liszbinski RB, Romao PRT, Rodrigues Junior LC, et al
     Nanoparticle vaccines against viral infections.
     Arch Virol. 2018 May 4. pii: 10.1007/s00705-018-3856.
     PubMed     Abstract available
     
     
     April 2018
104. HOSSAN MS, Fatima A, Rahmatullah M, Khoo TJ, et al
     Antiviral activity of Embelia ribes Burm. f. against influenza virus in vitro.
     Arch Virol. 2018 Apr 10. pii: 10.1007/s00705-018-3842.
     PubMed     Abstract available
     
     
     
105. NEROME K, Shimizu K, Zukeran S, Igarashi Y, et al
     Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia azedarach L.
     Arch Virol. 2018 Apr 9. pii: 10.1007/s00705-018-3830.
     PubMed     Abstract available
     
     
     
106. NAGY A, Dan A, Cernikova L, Vitaskova E, et al
     Microevolution and independent incursions as main forces shaping H5 Hemagglutinin diversity during a H5N8/H5N5 highly pathogenic avian influenza outbreak in Czech Republic in 2017.
     Arch Virol. 2018 Apr 5. pii: 10.1007/s00705-018-3833.
     PubMed     Abstract available
     
     
     
107. ZHENG XY, Xu YJ, Guan WJ, Lin LF, et al
     Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review.
     Arch Virol. 2018;163:845-853.
     PubMed     Abstract available
     
     
     March 2018
108. CAO X, Liu X, Zheng S, Xu L, et al
     Isolation and characterization of an avian-origin H3N8 canine influenza virus from a dog in eastern China.
     Arch Virol. 2018 Mar 20. pii: 10.1007/s00705-018-3818.
     PubMed     Abstract available
     
     
     
109. QI X, An X, Jiao Y, Yu H, et al
     Co-circulation of multiple genotypes of influenza A (H7N9) viruses in eastern China, 2016-2017.
     Arch Virol. 2018 Mar 14. pii: 10.1007/s00705-018-3800.
     PubMed     Abstract available
     
     
     
110. TAKIZAWA N, Kimura T, Watanabe T, Shibasaki M, et al
     Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
     Arch Virol. 2018 Mar 1. pii: 10.1007/s00705-018-3779.
     PubMed     Abstract available
     
     
     February 2018
111. YANG F, Wu H, Liu F, Lu X, et al
     Establishment of a multiplex real-time RT-PCR assay for rapid identification of H6 subtype avian influenza viruses.
     Arch Virol. 2018 Feb 21. pii: 10.1007/s00705-018-3773.
     PubMed     Abstract available
     
     
     
112. HASHEM AM, Azhar EI, Shalhoub S, Abujamel TS, et al
     Genetic characterization and diversity of circulating influenza A/H1N1pdm09 viruses isolated in Jeddah, Saudi Arabia between 2014 and 2015.
     Arch Virol. 2018 Feb 2. pii: 10.1007/s00705-018-3732.
     PubMed     Abstract available
     
     
     
113. TSUNEKUNI R, Yaguchi Y, Kashima Y, Yamashita K, et al
     Spatial transmission of H5N6 highly pathogenic avian influenza viruses among wild birds in Ibaraki Prefecture, Japan, 2016-2017.
     Arch Virol. 2018 Feb 1. pii: 10.1007/s00705-018-3752.
     PubMed     Abstract available
     
     
     January 2018
114. KOO BS, Kim HK, Song D, Na W, et al
     Virological and pathological characterization of an avian H1N1 influenza A virus.
     Arch Virol. 2018 Jan 24. pii: 10.1007/s00705-018-3730.
     PubMed     Abstract available
     
     
     
115. KUMAR B, Asha K, Khanna M, Ronsard L, et al
     The emerging influenza virus threat: status and new prospects for its therapy and control.
     Arch Virol. 2018 Jan 10. pii: 10.1007/s00705-018-3708.
     PubMed     Abstract available
     
     
     
116. LIU K, Gu M, Hu S, Gao R, et al
     Genetic and biological characterization of three poultry-origin H5N6 avian influenza viruses with all internal genes from genotype S H9N2 viruses.
     Arch Virol. 2018 Jan 6. pii: 10.1007/s00705-017-3695.
     PubMed     Abstract available
     
     
     
117. NAKAGAWA H, Okuya K, Kawabata T, Matsuu A, et al
     Genetic characterization of low-pathogenic avian influenza viruses isolated on the Izumi plain in Japan: possible association of dynamic movements of wild birds with AIV evolution.
     Arch Virol. 2018 Jan 3. pii: 10.1007/s00705-017-3698.
     PubMed     Abstract available
     
     
     December 2017
118. BHOYE D, Cherian SS
     Computational analysis of the effect of polymerase acidic (PA) gene mutation F35L in the 2009 pandemic influenza A (H1N1) virus on binding aspects of mononucleotides in the endonuclease domain.
     Arch Virol. 2017 Dec 22. pii: 10.1007/s00705-017-3681.
     PubMed     Abstract available
     
     
     
119. KHODAMORADI S, Shenagari M, Kheiri MT, Sabahi F, et al
     IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.
     Arch Virol. 2017 Dec 21. pii: 10.1007/s00705-017-3682.
     PubMed     Abstract available
     
     
     
120. KIM HK, Kim HJ, Noh JY, Van Phan L, et al
     Serological evidence of H5-subtype influenza A virus infection in indigenous avian and mammalian species in Korea.
     Arch Virol. 2017 Dec 4. pii: 10.1007/s00705-017-3655.
     PubMed     Abstract available
     
     
     November 2017
121. WU H, Yang F, Lu R, Xu L, et al
     Isolation and molecular characterization of an H5N1 swine influenza virus in China in 2015.
     Arch Virol. 2017 Nov 21. doi: 10.1007/s00705-017-3638.
     PubMed     Abstract available
     
     
     October 2017
122. YU Z, Cheng K, Sun W, Zhang X, et al
     PB2 and HA mutations increase the virulence of highly pathogenic H5N5 clade 2.3.4.4 avian influenza virus in mice.
     Arch Virol. 2017 Oct 31. doi: 10.1007/s00705-017-3631.
     PubMed     Abstract available
     
     
     
123. MOASSER E, Behzadian F, Moattari A, Fotouhi F, et al
     Characterization of the neuraminidase genes from human influenza A viruses circulating in Iran from 2010 to 2015.
     Arch Virol. 2017 Oct 31. doi: 10.1007/s00705-017-3603.
     PubMed     Abstract available
     
     
     
124. KRISHNAVAJHALA HR, Williams J, Heidner H
     An influenza A virus vaccine based on an M2e-modified alphavirus.
     Arch Virol. 2017 Oct 27. doi: 10.1007/s00705-017-3578.
     PubMed     Abstract available
     
     
     
125. GOMAA MR, Kandeil A, El-Shesheny R, Shehata MM, et al
     Evidence of infection with avian, human, and swine influenza viruses in pigs in Cairo, Egypt.
     Arch Virol. 2017 Oct 26. doi: 10.1007/s00705-017-3619.
     PubMed     Abstract available
     
     
     September 2017
126. TURMAGAMBETOVA AS, Alexyuk PG, Bogoyavlenskiy AP, Zaitseva IA, et al
     Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
     Arch Virol. 2017 Sep 21. doi: 10.1007/s00705-017-3560.
     PubMed     Abstract available
     
     
     
127. WOO C, Kwon JH, Lee DH, Kim Y, et al
     Novel reassortant clade 2.3.4.4 avian influenza A (H5N8) virus in a grey heron in South Korea in 2017.
     Arch Virol. 2017 Sep 12. doi: 10.1007/s00705-017-3547.
     PubMed     Abstract available
     
     
     August 2017
128. ROOT JJ, Shriner SA, Ellis JW, VanDalen KK, et al
     Low viral doses are sufficient to infect cottontail rabbits with avian influenza A virus.
     Arch Virol. 2017 Aug 2. doi: 10.1007/s00705-017-3493.
     PubMed     Abstract available
     
     
     
129. BOONARKART C, Suptawiwat O, Sakorn K, Puthavathana P, et al
     Exposure to cold impairs interferon-induced antiviral defense.
     Arch Virol. 2017;162:2231-2237.
     PubMed     Abstract available
     
     
     July 2017
130. CUI Z, Hu J, Wang X, Gu M, et al
     The virulence factor PA protein of highly pathogenic H5N1 avian influenza virus inhibits NF-kappaB transcription in vitro.
     Arch Virol. 2017 Jul 25. doi: 10.1007/s00705-017-3496.
     PubMed     Abstract available
     
     
     
131. LEE IH, Jin SY, Seo SH
     Genetic and pathogenic analysis of a novel reassortant H5N6 influenza virus isolated from waterfowl in South Korea in 2016.
     Arch Virol. 2017 Jul 24. doi: 10.1007/s00705-017-3488.
     PubMed     Abstract available
     
     
     
132. CAO X, Yang F, Wu H, Xu L, et al
     Genetic characterization of novel reassortant H5N6-subtype influenza viruses isolated from cats in eastern China.
     Arch Virol. 2017 Jul 21. doi: 10.1007/s00705-017-3490.
     PubMed     Abstract available
     
     
     
133. WU H, Lu R, Peng X, Liu F, et al
     Characterization of reassortant H1-subtype avian influenza viruses isolated from poultry in Zhejiang Province in China from 2013 to 2015.
     Arch Virol. 2017 Jul 20. doi: 10.1007/s00705-017-3487.
     PubMed     Abstract available
     
     
     
134. WANG H, Guo S, Li Z, Xu X, et al
     Suspension culture process for H9N2 avian influenza virus (strain Re-2).
     Arch Virol. 2017 Jul 7. doi: 10.1007/s00705-017-3460.
     PubMed     Abstract available
     
     
     
135. HOSSEINI H, Ghalyanchilangeroudi A, Fallah Mehrabadi MH, Sediqian MS, et al
     Phylogenetic analysis of H9N2 avian influenza viruses in Afghanistan (2016-2017).
     Arch Virol. 2017 Jul 3. doi: 10.1007/s00705-017-3474.
     PubMed     Abstract available
     
     
     June 2017
136. NAM JH, Shim SM, Song EJ, Espano E, et al
     Rapid virulence shift of an H5N2 avian influenza virus during a single passage in mice.
     Arch Virol. 2017 Jun 29. doi: 10.1007/s00705-017-3451.
     PubMed     Abstract available
     
     
     
137. MOATASIM Y, Kandeil A, Mostafa A, Elghaffar SKA, et al
     Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses.
     Arch Virol. 2017 Jun 15. doi: 10.1007/s00705-017-3434.
     PubMed     Abstract available
     
     
     May 2017
138. LIU S, Zhang L, Yao Z, Xing L, et al
     In vitro and in vivo characterization of a novel H1N1/2009 influenza virus reassortant with an NS gene from a highly pathogenic H5N1 virus, isolated from a human.
     Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3408.
     PubMed     Abstract available
     
     
     
139. ROOT JJ, Shriner SA, Ellis JW, VanDalen KK, et al
     Transmission of H6N2 wild bird-origin influenza A virus among multiple bird species in a stacked-cage setting.
     Arch Virol. 2017 May 16. doi: 10.1007/s00705-017-3397.
     PubMed     Abstract available
     
     
     
140. ZHOU H, Zhao M, Li X, Zhang D, et al
     Clinical evaluation of the isothermal amplification assays for the detection of four common respiratory viruses in children with pneumonia.
     Arch Virol. 2017;162:1311-1318.
     PubMed     Abstract available
     
     
     April 2017
141. LIU C, Li X, Zhang J, Yang L, et al
     Isolation and genomic characterization of a canine parainfluenza virus type 5 strain in China.
     Arch Virol. 2017 Apr 28. doi: 10.1007/s00705-017-3387.
     PubMed     Abstract available
     
     
     
142. MATSUURA R, Takada M, Kokuho T, Tsuboi T, et al
     A single L288I substitution in the fusion protein of bovine parainfluenza virus type 3 enhances virus growth in semi-suitable cell lines.
     Arch Virol. 2017 Apr 27. doi: 10.1007/s00705-017-3378.
     PubMed     Abstract available
     
     
     
143. GRONSANG D, Bui AN, Trinh DQ, Bui VN, et al
     Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
     Arch Virol. 2017 Apr 12. doi: 10.1007/s00705-017-3350.
     PubMed     Abstract available
     
     
     March 2017
144. ABOLNIK C
     Evolution of H5 highly pathogenic avian influenza: sequence data indicate stepwise changes in the cleavage site.
     Arch Virol. 2017 Mar 30. doi: 10.1007/s00705-017-3337.
     PubMed     Abstract available
     
     
     
145. MOASSER E, Behzadian F, Moattari A, Fotouhi F, et al
     Molecular characterization and phylogenetic analysis of human influenza A viruses isolated in Iran during the 2014-2015 season.
     Arch Virol. 2017 Mar 22. doi: 10.1007/s00705-017-3323.
     PubMed     Abstract available
     
     
     
146. JAGADESH A, Salam AA, Zadeh VR, Krishnan A, et al
     Molecular characterization of neuraminidase genes of influenza A(H3N2) viruses circulating in Southwest India from 2009 to 2013.
     Arch Virol. 2017 Mar 7. doi: 10.1007/s00705-017-3306.
     PubMed     Abstract available
     
     
     February 2017
147. LIAO SH, Li Y, Lai YN, Liu N, et al
     Ribavirin attenuates the respiratory immune responses to influenza viral infection in mice.
     Arch Virol. 2017 Feb 27. doi: 10.1007/s00705-017-3291.
     PubMed     Abstract available
     
     
     
148. SAAVEDRA-MONTANEZ M, Castillo-Juarez H, Sanchez-Betancourt I, Rivera-Benitez JF, et al
     Serological study of influenza viruses in veterinarians working with swine in Mexico.
     Arch Virol. 2017 Feb 23. doi: 10.1007/s00705-017-3282.
     PubMed     Abstract available
     
     
     January 2017
149. ZHAI JQ, Zhai SL, Lin T, Liu JK, et al
     First complete genome sequence of parainfluenza virus 5 isolated from lesser panda.
     Arch Virol. 2017 Jan 30. doi: 10.1007/s00705-017-3245.
     PubMed     Abstract available
     
     
     
150. MARCHENKO VY, Susloparov IM, Komissarov AB, Fadeev A, et al
     Reintroduction of highly pathogenic avian influenza A/H5N8 virus of clade 2.3.4.4. in Russia.
     Arch Virol. 2017 Jan 30. doi: 10.1007/s00705-017-3246.
     PubMed     Abstract available
     
     
     
151. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
     Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
     Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
     PubMed     Abstract available
     
     
     
152. JIA Y, Yang J, Wang Z, Du Y, et al
     Genetic properties and pathogenicity of a novel reassortant H10N5 influenza virus from wild birds.
     Arch Virol. 2017 Jan 23. doi: 10.1007/s00705-017-3234.
     PubMed     Abstract available
     
     
     
153. YANG CH, Li HC, Shiu YL, Ku TS, et al
     Influenza A virus upregulates PRPF8 gene expression to increase virus production.
     Arch Virol. 2017 Jan 21. doi: 10.1007/s00705-016-3210.
     PubMed     Abstract available
     
     
     
154. WU H, Lu R, Peng X, Peng X, et al
     Molecular characterization of a novel reassortant H7N6 subtype avian influenza virus from poultry in Eastern China, in 2016.
     Arch Virol. 2017 Jan 19. doi: 10.1007/s00705-017-3219.
     PubMed     Abstract available
     
     
     
155. LEE IH, Kim HS, Seo SH
     Porcine mast cells infected with H1N1 influenza virus release histamine and inflammatory cytokines and chemokines.
     Arch Virol. 2017 Jan 2. doi: 10.1007/s00705-016-3216.
     PubMed     Abstract available
     
     
     December 2016
156. YAN Y, Gu JY, Yuan ZC, Chen XY, et al
     Genetic characterization of H9N2 avian influenza virus in plateau pikas in the Qinghai Lake region of China.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
157. BHOWMICK S, Chakravarty C, Sellathamby S, Lal SK, et al
     The influenza A virus matrix protein 2 undergoes retrograde transport from the endoplasmic reticulum into the cytoplasm and bypasses cytoplasmic proteasomal degradation.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     November 2016
158. BASHIR U, Nisar N, Arshad Y, Alam MM, et al
     Respiratory syncytial virus and influenza are the key viral pathogens in children <2 years hospitalized with bronchiolitis and pneumonia in Islamabad Pakistan.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
159. SHITTU I, Meseko CA, Gado DA, Olawuyi AK, et al
     Highly pathogenic avian influenza (H5N1) in Nigeria in 2015: evidence of widespread circulation of WA2 clade 2.3.2.1c.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
160. EL-SHESHENY R, Mostafa A, Kandeil A, Mahmoud SH, et al
     Biological characterization of highly pathogenic avian influenza H5N1 viruses that infected humans in Egypt in 2014-2015.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
161. QU X, Ding X, Duan M, Yang J, et al
     Influenza virus infection induces translocation of apoptosis-inducing factor (AIF) in A549 cells: role of AIF in apoptosis and viral propagation.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
162. BHAT S, Nagarajan S, Kumar M, Murugkar HV, et al
     Antigenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from poultry in India, 2006-2015.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     October 2016
163. INDALAO IL, Sawabuchi T, Takahashi E, Kido H, et al
     IL-1beta is a key cytokine that induces trypsin upregulation in the influenza virus-cytokine-trypsin cycle.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
164. SUN Y, Yang C, Li J, Li L, et al
     Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
165. KYDYRMANOV A, Sayatov M, Karamendin K, Zhumatov K, et al
     Monitoring of influenza A viruses in wild bird populations in Kazakhstan in 2002-2009.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     September 2016
166. UCHIDA Y, Kanehira K, Takemae N, Hikono H, et al
     Susceptibility of chickens, quail, and pigeons to an H7N9 human influenza virus and subsequent egg-passaged strains.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     
167. KAEWBORISUTH C, Kaplan B, Zanin M, Finkelstein D, et al
     G45R on nonstructural protein 1 of influenza A virus contributes to virulence by increasing the expression of proinflammatory cytokines in mice.
     Arch Virol. 2016.
     PubMed     Abstract available
     
     
     July 2016
168. GUAN L, Zhao LQ, Zhou HY, Nie K, et al
     Reverse transcription genome exponential amplification reaction assay for rapid and universal detection of human rhinoviruses.
     Arch Virol. 2016;161:1891-8.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: